Protein Key To Growth Of Pancreatic Cancer
Links shared publicly online about this topic.
- 836total visits
Protein Key To Growth Of Pancreatic Cancer
View full resource at medicalnewstoday.com
Tags: Pancreatic Disease, Cancer, Pancreatic Cancer, Disease and Condition, Protein, disease, Education
Most Recently Shared on September 30, 2010 at 1:05 pm By:
Protein Key To Growth Of Pancreatic Cancer http://mnt.to/3Kx2 #pancreaticcancer
Cancer research targets a key cell protein - latimes.com
latimes.com — “The cell protein CD47 sits on the surface of tumor cells and renders them resistant to attacks from a cancer patient's immune system. Blocking its signals slows tumor growth in mice, researchers find.” View full resource at latimes.com
Most Recently Shared on March 27, 2012 at 6:18 pm By:
LA Times Health News Health News
Cancer research targets a key cell protein http://t.co/zI2TsCyj
Cancer research targets a key cell protein - latimes.com
latimes.com — “The cell protein CD47 sits on the surface of tumor cells and renders them resistant to attacks from a cancer patient's immune system. Blocking its signals slows tumor growth in mice, researchers find.” View full resource at latimes.com
Most Recently Shared on March 27, 2012 at 11:36 am By:
Dr Steven Tucker Doctor, Internist, Oncologist, and Physician
Targeting CD47 stalls at least 7 cancer types http://t.co/3WrqQokh
Cancer research targets a key cell protein - latimes.com
latimes.com — “The cell protein CD47 sits on the surface of tumor cells and renders them resistant to attacks from a cancer patient's immune system. Blocking its signals slows tumor growth in mice, researchers find.” View full resource at latimes.com
Most Recently Shared on March 27, 2012 at 7:21 am By:
Cancer research targets a key cell protein: The cell protein CD47 sits on the surface of tumor cells and fends o... http://t.co/sAZmpqzI
Cancer research targets a key cell protein - latimes.com
latimes.com — “The cell protein CD47 sits on the surface of tumor cells and renders them resistant to attacks from a cancer patient's immune system. Blocking its signals slows tumor growth in mice, researchers find.” View full resource at latimes.com
Most Recently Shared on March 27, 2012 at 7:08 am By:
Cancer research targets a key cell protein: The cell protein CD47 sits on the surface of tumor cells and fends o... http://t.co/RVMJ0eZW
Blocking Receptor In Key Hormone Fires Up Enzyme To Kill Pancreatic Cancer Cells - Health News - redOrbit
redorbit.com — “Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.” View full resource at redorbit.com
Most Recently Shared on August 12, 2011 at 5:04 am By:
Endocrinology Wisdom OW Health
Blocking Receptor In Key Hormone Fires Up Enzyme To Kill Pancreatic Cancer Cells: Thomas Jefferson University re... http://bit.ly/npf7se
Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells
labspaces.net — “Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.” View full resource at labspaces.net
Most Recently Shared on August 11, 2011 at 1:30 pm By:
Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells - http://is.gd/GKtFaS
Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells
sciencedaily.com — “Pancreatic cancer researchers have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.” View full resource at sciencedaily.com
Most Recently Shared on August 11, 2011 at 4:54 am By:
Endocrinology Wisdom OW Health
Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells: Pancreatic cancer researchers ... http://bit.ly/pA9AhR
Peptides for fighting ovarian cancer developed
medicalxpress.com — “A team of German and Italian EU-funded scientists has designed peptides that can target the protein-protein interface of an enzyme that plays a key part in the DNA synthesis crucial for cancer growth.” View full resource at medicalxpress.com
Most Recently Shared on August 8, 2011 at 2:22 pm By:
Peptides for fighting ovarian cancer developed http://bit.ly/mSaf7F
Potential new eye tumor treatment discovered
sciencedaily.com — “New research demonstrates that a specific small segment of RNA could play a key role in the growth of a type of malignant childhood eye tumor called retinoblastoma. The tumor is associated with mutations of a protein called Rb, which is also involved with other types of cancers, including lung, brain, breast and bone. Their work could result in a new therapeutic target.” View full resource at sciencedaily.com
Most Recently Shared on August 5, 2011 at 4:37 am By:
Matthew Katz Doctor, Oncologist, Radiation Oncologist, and Physician
Potential new eye tumor retinoblastoma treatment discovered: http://t.co/e7G12VU via @ScienceDaily #esearch
Scientists design octapeptides to fight drug resistant ovarian cancer cells
news-medical.net — “Italian and German scientists have designed peptides to target the protein-protein interface of a key enzyme in DNA synthesis crucial for cancer growth. The peptides act by a novel inhibitory mechanism and curb cancer cell growth in drug resistant ovarian cancer cells.” View full resource at news-medical.net
Most Recently Shared on August 2, 2011 at 9:21 am By:
Ovarian Cancer News: Scientists design octapeptides to fight drug resistant ovarian cancer cells: Italian and Ge... http://bit.ly/obPVCl
New peptides to fight ovarian cancer drug resistance - QualityPoint Technologies
qualitypointtech.net — “Italian and German scientists have designed peptides to target the protein-protein interface of a key enzyme in DNA synthesis crucial for cancer growth. The peptides act by a novel inhibitory mechanism and curb cancer cell growth in drug resistant ovarian cancer cells. The interdisciplinary research project was led by the University of Modena and Reggio Emilia (UNIMORE) and the Heidelberg Institute for Theoretical Studies (HITS).” View full resource at qualitypointtech.net
Most Recently Shared on August 1, 2011 at 5:00 pm By:
New peptides to fight ovarian cancer drug resistance: Italian and German scientists have designed peptides to targ... http://bit.ly/naeth6
Key metabolic pathway implicated in intractable form of breast cancer
sciencedaily.com — “Using a new in vivo screening system, researchers have identified a protein in a key metabolic pathway that is essential in estrogen receptor (ER)-negative breast cancer. When the expression of the gene that codes for this protein -- phosphoglycerate dehydrogenase or PHGDH -- is suppressed in tumors and cell lines with an overabundance of the protein, the rate of cellular growth declines markedly. PHGDH is overexpressed in approximately 70 percent of ER-negative breast cancer patients.” View full resource at sciencedaily.com
Most Recently Shared on July 19, 2011 at 11:33 pm By:
Key metabolic pathway implicated in intractable form of #breast #cancer: http://t.co/ByESZq6 via @AddThis #oncology
Key Metabolic Pathway Implicated in Intractable Form of Breast Cancer
newswise.com — “Whitehead Institute researchers have identified a protein that is essential in estrogen receptor (ER)-negative breast cancer. When the expression of the gene that codes for this protein—PHGDH—is suppressed in tumors and cell lines with an overabundance of the protein, the rate of cellular growth declines markedly. PHGDH is overexpressed in approximately 70% of ER-negative breast cancer patients.” View full resource at newswise.com
Most Recently Shared on July 18, 2011 at 9:48 pm By:
#health news: Key Metabolic Pathway Implicated in Intractable Form of Breast Cancer: Whitehead Institute researc... http://bit.ly/qZxL7A
Key metabolic pathway implicated in intractable form of breast cancer
sciencedaily.com — “Using a new in vivo screening system, researchers have identified a protein in a key metabolic pathway that is essential in estrogen receptor (ER)-negative breast cancer. When the expression of the gene that codes for this protein -- phosphoglycerate dehydrogenase or PHGDH -- is suppressed in tumors and cell lines with an overabundance of the protein, the rate of cellular growth declines markedly. PHGDH is overexpressed in approximately 70 percent of ER-negative breast cancer patients.” View full resource at sciencedaily.com
Most Recently Shared on July 18, 2011 at 9:39 pm By:
Key metabolic pathway implicated in intractable form of breast cancer http://bit.ly/nM9FsB
Key metabolic pathway implicated in intractable form of breast cancer
sciencedaily.com — “Using a new in vivo screening system, researchers have identified a protein in a key metabolic pathway that is essential in estrogen receptor (ER)-negative breast cancer. When the expression of the gene that codes for this protein -- phosphoglycerate dehydrogenase or PHGDH -- is suppressed in tumors and cell lines with an overabundance of the protein, the rate of cellular growth declines markedly. PHGDH is overexpressed in approximately 70 percent of ER-negative breast cancer patients.” View full resource at sciencedaily.com
Most Recently Shared on July 18, 2011 at 9:21 pm By:
Key metabolic pathway implicated in intractable form of breast cancer: Using a new in vivo screening syste... http://tinyurl.com/3wu28th
Advertisement
